This project is a fundamental study examining the molecular-level processing and receptor interactions of peptides produced from the cocaine- and amphetamine-regulated transcript (CART), which plays important roles in glucose regulation and incretin secretion and may serve as a novel target for several diseases, including type 2 diabetes. However, progress in pursuing CART peptide signaling as a therapeutic target has been limited due to: ) the lack of rigorous evaluation of the post-translational processing of CART peptides across tissues; and 2) no receptor for CART peptides has been identified in any tissue. Based on strong literature evidence, we hypothesize that CART peptides are processed differently across peripheral tissues (including with uncharacterized post-translational modifications) and that there exist CART-specific cell-surface receptors responsible for facilitating their known biological functions. Here, we test these hypotheses through a combination of novel mass spectrometry (MS) and chemical biology approaches. Because the majority of studies on CART signaling focus on only one peptide form in the brain, our studies are innovative in that they rigorously evaluate additional molecular forms of CART peptides, do so in peripheral tissues associated with glucose regulation (in contrast to most studies, which focus on effects in the brain), and utilize novel techniques to identify the first receptor for CART peptides. The long-term objective of this research is to gain new insight into the molecular-level details of CART signaling to aid in the evaluation of CART signaling as a therapeutic target for disorders involved in glucose regulation.
In Aim 1, we will develop a targeted MS assay to identify and quantify the final processed forms of CART peptides and use this assay to rigorously compare the relative processing of CART peptides across several cell types. To gain insight into the relevance of these forms for glucose homeostasis, we will evaluate the ability of each of these peptide forms to activate signaling pathways identified for CART in a model pancreatic beta cell line.
In Aim 2, we will develop a novel MS-based technology, function-driven enrichment, to identify peptide receptor(s) that overcomes the limitations of many previous approaches to identify peptide-receptor interactions. We will apply this approach to identify the CART peptide receptor(s) present on the surface of model cells, which will be the first CART peptide receptor identified. Importantly, the function-driven enrichment approach developed here is not limited to determining the receptor for CART, and can be generalized to identify the receptors for other biologically active hormones and neuropeptides of interest in future studies. Overall, this research will significantly advance our understanding of cell-cell signaling in several different cell types, and may establish CART signaling as a novel therapeutic target.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM113126-05
Application #
10231552
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Mcguirl, Michele
Project Start
2020-08-01
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Nebraska Lincoln
Department
Type
DUNS #
555456995
City
Lincoln
State
NE
Country
United States
Zip Code
68503
Catazaro, Jonathan; Andrews, Tessa; Milkovic, Nicole M et al. (2018) 15N CEST data and traditional model-free analysis capture fast internal dynamics of DJ-1. Anal Biochem 542:24-28
Yang, Yongliang; Yu, Jing; Monemian Esfahani, Amir et al. (2018) Single-cell membrane drug delivery using porous pen nanodeposition. Nanoscale 10:12704-12712
Lai, Rui; Dodds, Eric D; Li, Hui (2018) Molecular dynamics simulation of ion mobility in gases. J Chem Phys 148:064109
Casey, Carol A; Thomes, Paul; Manca, Sonia et al. (2018) Giantin Is Required for Post-Alcohol Recovery of Golgi in Liver Cells. Biomolecules 8:
Gardner, Stewart G; Marshall, Darrell D; Daum, Robert S et al. (2018) Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility. Antimicrob Agents Chemother 62:
Yang, Ruiguo; Broussard, Joshua A; Green, Kathleen J et al. (2018) Techniques to stimulate and interrogate cell-cell adhesion mechanics. Extreme Mech Lett 20:125-139
Natarajan, Gopalakrishnan; Perriotte-Olson, Curtis; Bhinderwala, Fatema et al. (2017) Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling. Transl Res 188:10-26
Bernier, Michel; Catazaro, Jonathan; Singh, Nagendra S et al. (2017) GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts. Int J Cancer 141:2131-2142
Duszenko, Nikolas; Buan, Nicole R (2017) Physiological Evidence for Isopotential Tunneling in the Electron Transport Chain of Methane-Producing Archaea. Appl Environ Microbiol 83:
Zhou, Xinqi; Lesiak, Lauren; Lai, Rui et al. (2017) Chemoselective Alteration of Fluorophore Scaffolds as a Strategy for the Development of Ratiometric Chemodosimeters. Angew Chem Int Ed Engl 56:4197-4200

Showing the most recent 10 out of 17 publications